Auspex Pharmaceuticals Secures $12,000,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6d17486f-3d06-4e88-8504-f860e11f63aa&Preview=1 -
Date
7/20/2010 -
Company Name
Auspex Pharmaceuticals -
Mailing Address
1261 Liberty Way Vista, CA 92081-8356 -
Company Description
Auspex Pharmaceuticals is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs. For more than five years the company has worked to apply its targeted deuteration strategy to drug molecules across multiple therapeutic areas, secure a proprietary position on several hundred compounds and initiate development on multiple clinical candidates. -
Website
http://www.auspexpharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$12,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Undisclosed
